skip to content
Hypoglycaemic Agents
Follow the links below to find information on the role of drugs and diet in controlling blood sugar levels.
Reviewed January 2012
Related HealthInsite Topics
HealthInsite Topic Page
Links to information on the benefits and role of insulin, especially the role of insulin in the treatment of diabetes.
26 Resources Found
Results 1 to 20 displayed. 1 2
| Title: | Pioglitazone and risk of bladder cancer |
|---|---|
| Publisher: | Australian Government Department of Health and Ageing |
| Description: | The TGA is advising health professionals and consumers that use of the diabetes medicine, pioglitazone, for more than a year may be associated with an increased risk of bladder cancer |
| Date: | Jul 2011 |
| Title: | Diabetes: tablets for type 2 diabetes - myDr.com.au |
|---|---|
| Publisher: | myDr |
| Description: | Tablets used to treat Type 2 diabetes are known as oral hypoglycaemics or antihyperglycaemics. |
| Date: | Jul 2011 |
| Title: | Saxagliptin (Onglyza) for type 2 diabetes |
|---|---|
| Publisher: | National Prescribing Service |
| Description: | Saxagliptin (Onglyza) is a medicine to help control blood glucose in type 2 diabetes. Find out who can take it, how it fits with other diabetes medicines and its side effects. |
| Date: | Jul 2011 |
| Title: | Interventions for latent autoimmune diabetes (LADA) in adults |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | LADA is a condition that at diagnosis looks like type 2 diabetes (non-insulin requiring diabetes mellitus) but actually is a type 1 diabetes, where the patient will become insulin requiring. In the UK approximately 3.6% of people who look like they have... |
| Date: | Dec 2010 |
| Title: | Exenatide (Byetta) for type 2 diabetes |
|---|---|
| Publisher: | National Prescribing Service |
| Description: | Information on exenatide (Byetta) for type 2 diabetes |
| Date: | Dec 2010 |
| Title: | Rosiglitazone (Avandia/Avandamet) |
|---|---|
| Publisher: | Australian Government Department of Health and Ageing |
| Description: | The TGA is aware of recent regulatory decisions by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regarding the status of rosglitazone (Avandia and Avandamet) |
| Date: | Oct 2010 |
| Title: | Oral anti-diabetic agents for women with pre-existing diabetes mellitus, impaired glucose tolerance or previous gestational diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Pregnant women with type 1 or type 2 diabetes are at a greater risk of adverse outcomes in pregnancy, such as miscarriage or large babies and preterm birth. Being pregnant can trigger diabetes in women with impaired glucose tolerance or can accelerate t... |
| Date: | Aug 2010 |
| Title: | Vildagliptin (Galvus) for type 2 diabetes |
|---|---|
| Publisher: | National Prescribing Service |
| Description: | This Medicine Update is for people who are taking, or thinking about taking, vildagliptin for type 2 diabetes. |
| Date: | Aug 2010 |
| Title: | Sitagliptin (Januvia) for type 2 diabetes |
|---|---|
| Publisher: | National Prescribing Service |
| Description: | This Medicine Update is for people who are taking, or thinking about taking, sitagliptin for type 2 diabetes. |
| Date: | Aug 2010 |
| Title: | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome affects menstruation, prevents ovulation and causes hirsutism. Women with PCOS are also at risk of developing metabolic syndrome and have an increased rate of insulin resistance compared with women of similar body weight with n... |
| Date: | Aug 2009 |
| Title: | Strict control compared with conventional glycaemic control for preventing surgical site infections in adults |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Wound-related infections that complicate operations ( |
| Date: | Mar 2009 |
| Title: | Have glitazones lost their sparkle? |
|---|---|
| Publisher: | Australian Prescriber |
| Description: | The thiazolidinediones, better known as 'glitazones', are under suspicion of causing serious, previously unsuspected adverse effects. Given these concerns, what can be said about the role of thiazolidinediones in third-line therapy of poorly controlled type 2 diabetes? |
| Date: | Jun 2008 |
| Title: | Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome (PCOS) is characterised by chronic failure or absence of ovulation (anovulation) and excessive production of male hormones (hyperandrogenism) with the clinical manifestations of irregular menstrual cycles, infertility, hirsutis... |
| Date: | Feb 2008 |
| Title: | Metformin in pregnancy and lactation |
|---|---|
| Publisher: | Australian Prescriber |
| Description: | Metformin improves insulin sensitivity and reduces hepatic glucose output in patients with diabetes. |
| Date: | Jun 2007 |
| Title: | Diabetes during pregnancy (Comments for Consumers) |
|---|---|
| Publisher: | Australian Prescriber |
| Description: | Some women may need treatment for diabetes during pregnancy. If they have too much sugar (glucose) in their blood it can affect the growth of their unborn baby. |
| Date: | Jun 2007 |
| Title: | Rosiglitazone for type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diseases of the heart and blood vessels account for approximately 70% of all mortality in people with diabetes. Compared to their non-diabetic counterparts the relative risk of mortality caused by disorders of the heart and blood vessels is two to three... |
| Date: | Apr 2007 |
| Title: | Insulin-sensitising drugs versus the combined oral contraceptive pill for symptoms and risks of polycystic ovary syndrome. |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with polycystic ovary syndrome suffer from excessive hairiness (hirsutism), irregular periods, and acne. They are also at greater risk of developing diabetes, cardiovascular disease, and endometrial cancer. In women with polycystic ovary syndrome ... |
| Date: | Nov 2006 |
| Title: | No evidence to support or refute drugs trying to influence insulin resistance in patients with non-alcoholic fatty liver disease and/or steatohepatitis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Non-alcoholic fatty liver disease and steatohepatitis are clinical-pathological conditions characterised by fatty deposition in the hepatocytes without excessive alcohol intake. Hepatic injury might be ameliorated by drugs improving insulin resistance. ... |
| Date: | Nov 2006 |
| Title: | Meglitinide analogues for type 2 diabetes mellitus |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | In type 2 diabetes mellitus, impairment of insulin secretion is an important component of the disease. The meglitinide analogues ( |
| Date: | Oct 2006 |
| Title: | Managing diabetes with drugs and non-drug interventions |
|---|---|
| Publisher: | National Prescribing Service |
| Description: | Educates patients with diabetes mellitus on medicines management and non-drug interventions. |
| Date: | Jun 2006 |
Results 1 to 20 displayed. 1 2
